Year Founded
1968
Ownership
Public
Employees
~5000
Therapeutic Areas
Women's HealthMen's HealthDermatology
Stage
Commercial
Modalities
Small molecule

Warner Chilcott General Information

Commercial pharmaceutical company focused on women's health, urology, gastroenterology and dermatology. Acquired by Actavis (now Allergan) in 2013 for $8.5B.

Contact Information

Website
Primary Industry
[ "Pharma" ]
Corporate Office
Rockaway, New Jersey
United States

Drug Pipeline

actonel
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Warner Chilcott's pipeline data

Book a demo

Key Partnerships

Actavis

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Warner Chilcott Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Warner Chilcott's complete valuation and funding history, request access »

Warner Chilcott Investors

J.P. Morgan
Investor Type: Venture Capital
Holding: Minority
Bain Capital
Investor Type: Venture Capital
Holding: Minority
aPriori Capital Partners
Investor Type: Venture Capital
Holding: Minority
Investor Name
Investor Type
Holding
Investor Name
Investor Type
Holding
You're viewing 3 of 4 investors. Get the full list »